Elicio Therapeutics, Inc.
ELTX
$4.80
$0.040.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.00M | -18.84M | -7.23M | -11.83M | -8.95M |
| Total Depreciation and Amortization | 305.00K | 290.00K | 293.00K | 290.00K | 286.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.27M | 9.51M | -3.27M | 2.18M | 397.00K |
| Change in Net Operating Assets | 3.69M | 1.76M | 1.27M | -2.76M | -1.63M |
| Cash from Operations | -8.74M | -7.27M | -8.93M | -12.12M | -9.90M |
| Capital Expenditure | -45.00K | 0.00 | -42.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 3.00K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -45.00K | 0.00 | -42.00K | 3.00K | 0.00 |
| Total Debt Issued | 0.00 | 19.73M | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 227.00K | 11.58M | 316.00K | 11.02M | 7.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -549.00K | -- | -- | 2.00K |
| Cash from Financing | 227.00K | 30.75M | 316.00K | 11.02M | 7.00M |
| Foreign Exchange rate Adjustments | 27.00K | 36.00K | -41.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.54M | 23.52M | -8.70M | -1.10M | -2.89M |